Active Ingredient History
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome, granulomatosis with polyangiitis, and following organ transplant, among other conditions. It is taken by mouth or injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 3)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 1/Phase 2)
Adrenal Cortex Neoplasms (Phase 1)
Adrenocortical Carcinoma (Phase 1)
Adrenoleukodystrophy (Phase 2/Phase 3)
Aged (Phase 2)
Allergy and Immunology (Phase 2/Phase 3)
Allografts (Phase 2)
alpha-Mannosidosis (Phase 2)
Alzheimer Disease (Phase 1)
Amyloidosis (Phase 3)
Anemia (Phase 4)
Anemia, Aplastic (Phase 4)
Anemia, Diamond-Blackfan (Phase 2/Phase 3)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Refractory (Phase 3)
Anemia, Sickle Cell (Phase 2/Phase 3)
Anthracyclines (Phase 2)
Antibodies, Neoplasm (Phase 1/Phase 2)
Antigens, CD (Phase 2)
Antigens, CD19 (Phase 1/Phase 2)
Anti-Inflammatory Agents (Phase 2/Phase 3)
Anus Neoplasms (Phase 2)
Arachnoiditis (Phase 2/Phase 3)
Arthritis, Rheumatoid (Phase 2)
Aspartylglucosaminuria (Phase 2)
Autoimmune Diseases (Phase 3)
Autoimmune Diseases of the Nervous System (Early Phase 1)
Basal Cell Nevus Syndrome (Phase 2)
Beckwith-Wiedemann Syndrome (Phase 3)
Behcet Syndrome (Phase 3)
beta-Thalassemia (Phase 4)
Biomarkers (Phase 1)
Blood Protein Disorders (Phase 2)
Bone Marrow Cells (Phase 2)
Bone Marrow Diseases (Phase 1)
Bone Marrow Failure Disorders (Phase 3)
Bone Marrow Transplantation (Phase 2/Phase 3)
Bone Neoplasms (Phase 2)
Bortezomib (Phase 2)
Brain Neoplasms (Phase 3)
BRCA1 Protein (Phase 2)
Breast Carcinoma In Situ (Phase 2)
Breast Diseases (Phase 2/Phase 3)
Breast Neoplasms, Male (Phase 2)
Burkitt Lymphoma (Phase 4)
Busulfan (Phase 2/Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 1)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Mucoepidermoid (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cardiotoxicity (Phase 3)
Castleman Disease (Phase 2)
Central Nervous System Neoplasms (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 1)
Chemotherapy, Adjuvant (Phase 3)
Cholangiocarcinoma (Phase 1/Phase 2)
Chondrosarcoma (Phase 2)
Chondrosarcoma, Mesenchymal (Phase 2)
Chordoma (Phase 1/Phase 2)
Choroid Plexus Neoplasms (Phase 3)
Chromosome Aberrations (Phase 2)
Churg-Strauss Syndrome (Phase 4)
Cognition Disorders (Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 2)
Common Variable Immunodeficiency (Phase 2)
Condylomata Acuminata (Phase 3)
Conjunctival Neoplasms (Phase 2)
Crohn Disease (Phase 2)
Cyclophosphamide (Phase 3)
Deficiency Diseases (Phase 2)
Depression (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 2)
Dexamethasone (Phase 2)
Diarrhea (Phase 2)
Diffuse Intrinsic Pontine Glioma (Phase 2)
Diploidy (Phase 2)
DNA Mismatch Repair (Phase 2)
Down Syndrome (Phase 3)
Doxorubicin (Phase 3)
Drug Evaluation (Phase 4)
Drugs, Investigational (Phase 2)
Drug Therapy (Phase 2/Phase 3)
Dyskeratosis Congenita (Phase 2/Phase 3)
Edema (Phase 2)
Encephalitis (Phase 2)
Endodermal Sinus Tumor (Phase 1)
Endometrial Neoplasms (Phase 2)
Endoscopy (Phase 2)
Enteropathy-Associated T-Cell Lymphoma (Phase 4)
Eosinophilic Granuloma (Phase 3)
Ependymoma (Phase 3)
Epidermolysis Bullosa (Phase 2)
Erythema (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2/Phase 3)
Fatigue Syndrome, Chronic (Phase 2)
Febrile Neutropenia (Phase 2)
Felty Syndrome (Phase 2)
Fever (Phase 3)
Fucosidosis (Phase 2/Phase 3)
Fusion Proteins, bcr-abl (Phase 2)
Gallbladder Neoplasms (Phase 1/Phase 2)
Ganglioneuroblastoma (Phase 3)
Gangliosidosis, GM1 (Phase 2/Phase 3)
Gastrointestinal Neoplasms (Phase 1/Phase 2)
GATA2 Transcription Factor (Phase 2)
Gaucher Disease (Phase 2/Phase 3)
Genetic Diseases, Inborn (Phase 2)
Geriatrics (Phase 3)
Germinoma (Phase 2)
Gestational Trophoblastic Disease (Phase 3)
Giant Cell Tumor of Bone (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 1/Phase 2)
Graft Rejection (Phase 2)
Graft Survival (Phase 2)
Graft vs Host Disease (Phase 4)
Granulocyte Colony-Stimulating Factor (Phase 2)
Granuloma (Phase 3)
Granulomatosis with Polyangiitis (Phase 4)
Granulomatous Disease, Chronic (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hearing Disorders (Phase 1/Phase 2)
Hematologic Diseases (Phase 3)
Hematologic Neoplasms (Phase 3)
Hematology (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 4)
Hemoglobinopathies (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 3)
Hemophilia A (Phase 3)
Hepatoblastoma (Phase 1)
Herpesvirus 8, Human (Phase 2)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV (Phase 2)
HIV Infections (Phase 4)
HTLV-I Infections (Phase 1)
Hypercholesterolemia (Phase 3)
Hypertension, Pulmonary (Phase 2)
Hypertrophy (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 3)
Immune System Diseases (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 4)
Immunoglobulin Light Chains (Phase 2)
Immunosuppression Therapy (Phase 4)
Infections (Phase 4)
Infertility (Phase 3)
Inflammatory Breast Neoplasms (Phase 3)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 3)
Kidney Transplantation (Phase 4)
Lenalidomide (Phase 2)
Leukemia (Phase 4)
Leukemia, B-Cell (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 4)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 4)
Leukemia, Neutrophilic, Chronic (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, B-Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 1)
Leukemia, T-Cell (Phase 2/Phase 3)
Leukodystrophy, Globoid Cell (Phase 2/Phase 3)
Leukodystrophy, Metachromatic (Phase 2/Phase 3)
Liposarcoma (Phase 1)
Liposarcoma, Myxoid (Phase 2)
Liver Neoplasms (Phase 2)
Liver Transplantation (Phase 1/Phase 2)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 3)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 4)
Lymphadenopathy (Phase 2)
Lymphatic Diseases (Phase 2)
Lymph Nodes (Phase 3)
Lymphocytosis (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma ()
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Follicular (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 4)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, Primary Effusion (Phase 1/Phase 2)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 4)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 4)
Maintenance (Phase 3)
Malnutrition (Phase 2)
Mannosidase Deficiency Diseases (Phase 2)
Mastocytosis (Phase 2)
Mediastinal Neoplasms (Phase 4)
Medulloblastoma (Phase 3)
Melanoma (Phase 3)
Melanoma, Experimental (Phase 2)
Membranes (Phase 3)
Meningioma (Phase 2)
Menopause (Phase 3)
Mesothelioma (Phase 2)
Mesothelioma, Malignant (Phase 2)
Metabolic Diseases (Phase 2)
Metabolism (Phase 1)
Metabolism, Inborn Errors (Phase 2)
Microsatellite Instability (Phase 2)
Microscopic Polyangiitis (Phase 4)
Mixed Connective Tissue Disease (Phase 2/Phase 3)
Mouth Neoplasms (Phase 2/Phase 3)
Mucopolysaccharidoses (Phase 2/Phase 3)
Mucopolysaccharidosis I (Phase 2)
Mucopolysaccharidosis II (Phase 2)
Mucopolysaccharidosis VI (Phase 2)
Mucopolysaccharidosis VII (Phase 2)
Mucositis (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Muscular Diseases (Phase 1)
Mutation (Phase 2)
Myasthenia Gravis (Phase 1)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 1)
Myeloablative Agonists (Phase 2)
Myelodysplastic-Myeloproliferative Diseases (Phase 2/Phase 3)
Myelodysplastic Syndromes (Phase 4)
Myeloid Cells (Phase 1)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 2)
Myositis (Phase 2/Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Nausea (Phase 3)
Neoadjuvant Therapy (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 2)
Neoplasms, Connective and Soft Tissue (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Squamous Cell (Phase 2)
Nephrotic Syndrome (Phase 3)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 1)
Neuroendocrine Tumors (Phase 2)
Neurofibrosarcoma (Phase 1)
Neuromyelitis Optica (Phase 2/Phase 3)
Neuronal Ceroid-Lipofuscinoses (Phase 2/Phase 3)
Neutropenia (Phase 3)
Niemann-Pick Diseases (Phase 2/Phase 3)
Niemann-Pick Disease, Type B (Phase 2)
Niemann-Pick Disease, Type C (Phase 2)
N-Myc Proto-Oncogene Protein (Phase 1/Phase 2)
Obesity (Phase 4)
Oncogenes (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 3)
Organ Transplantation (Phase 3)
Oropharyngeal Neoplasms (Phase 2)
Osteogenesis Imperfecta (Phase 1)
Osteopetrosis (Phase 2/Phase 3)
Osteosarcoma (Phase 2)
Ototoxicity (Phase 3)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 3)
Pain (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pancytopenia (Phase 2)
Papilloma (Phase 1)
Papillomavirus Infections (Phase 1)
Paraproteinemias (Phase 2)
Pathology (Phase 2/Phase 3)
Pediatrics (Phase 2)
Pemphigus (Phase 3)
Penile Neoplasms (Phase 2)
Peripheral Nerve Injuries (Phase 1/Phase 2)
Peritoneal Neoplasms (Phase 1)
Peroxisomal Disorders (Phase 2)
Plasma (Phase 3)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 3)
POEMS Syndrome (Phase 1)
Polyarteritis Nodosa (Phase 4)
Polycythemia Vera (Phase 2)
Postoperative Complications (Phase 3)
Precancerous Conditions (Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Primary Myelofibrosis (Phase 3)
Prognosis (Phase 2)
Prostatic Neoplasms (Phase 3)
Prosthesis Failure (Phase 2)
Pulmonary Fibrosis (Phase 3)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)
Radiotherapy (Early Phase 1)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 3)
Renal Insufficiency (Phase 4)
Retinal Neoplasms (Phase 3)
Retinoblastoma (Phase 3)
Retroperitoneal Fibrosis (Phase 4)
Retroperitoneal Neoplasms (Phase 1)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 4)
Rhabdomyosarcoma, Alveolar (Phase 3)
Rhabdomyosarcoma, Embryonal (Phase 3)
Risk Factors (Phase 2)
Safety (Phase 2)
Sandhoff Disease (Phase 2/Phase 3)
Sarcoidosis (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Clear Cell (Phase 1)
Sarcoma, Ewing (Phase 3)
Sarcoma, Myeloid (Phase 2)
Sarcoma, Synovial (Phase 1/Phase 2)
Scleritis (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 2/Phase 3)
Sepsis (Phase 3)
Severe Combined Immunodeficiency (Phase 2/Phase 3)
Sezary Syndrome (Phase 2)
Shwachman-Diamond Syndrome (Phase 2/Phase 3)
Skin Diseases (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Smoldering Multiple Myeloma (Phase 1/Phase 2)
Sphingolipidoses (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stem Cell Transplantation (Phase 2)
Stiff-Person Syndrome (Phase 1/Phase 2)
Stomach Neoplasms (Phase 2)
Sweat (Phase 2)
Tacrolimus (Phase 3)
Takayasu Arteritis (Phase 3)
Tay-Sachs Disease (Phase 2/Phase 3)
Testicular Neoplasms (Phase 3)
Thalassemia (Phase 2/Phase 3)
Thalidomide (Phase 3)
Therapeutics (Phase 1/Phase 2)
Thoracic Neoplasms (Phase 1/Phase 2)
Thrombasthenia (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 3)
Thymoma (Phase 2)
Thyroid Neoplasms (Phase 2)
Tissue Donors (Phase 2)
Translocation, Genetic (Phase 2)
Transplantation (Phase 4)
Transplantation, Autologous (Phase 2)
Transplantation, Homologous (Phase 2)
Treatment Refusal (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Tuberculosis (Phase 2/Phase 3)
Tuberculosis, Meningeal (Phase 2/Phase 3)
Tumor Suppressor Protein p53 (Phase 2/Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Vascular Grafting (Phase 3)
Vasculitis (Phase 4)
Virus Diseases (Phase 2/Phase 3)
Vulvar Diseases (Phase 1)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 3)
Weight Loss (Phase 2)
Whole-Body Irradiation (Phase 2/Phase 3)
Wilms Tumor (Phase 4)
Wiskott-Aldrich Syndrome (Phase 2)
Wolman Disease (Phase 2/Phase 3)
WT1 Proteins (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
